Jump Financial’s Avita Medical RCEL Stock Holding History

Jump Financial’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,985	Closed	-$234K	–	2162
2023 Q3	$234K	Sell	15,985 -8,515	-35%	-$144K	0.01%	1438
2023 Q2	$417K	Buy	24,500 +2,300	+10%	+$33.7K	0.02%	1119
2023 Q1	$310K	Buy	+22,200	New	+$236K	0.01%	1098
2022 Q3	–	Sell	-21,000	Closed	-$100K	–	1893
2022 Q2	$100K	Buy	+21,000	New	+$130K	﹤0.01%	1447

Other funds holding RCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jump Financial's RCEL Position: Q4 2023 in Review

Jump Financial sold out of Avita Medical (RCEL) in Q4 2023, closing a stake of 15,985 shares — an estimated $234K sold.

Jump Financial first reported a position in RCEL in Q2 2022 and held it in 4 quarters. The position peaked at $417K in Q2 2023. 84 funds tracked by Wall St. Rank hold RCEL as of Q4 2023.

Jump Financial reported no remaining Avita Medical position as of Q4 2023 after selling out during the quarter.
Jump Financial sold 15,985 Avita Medical shares in Q4 2023, an estimated $234K.
Jump Financial first reported a position in Avita Medical in Q2 2022 and held it in 4 quarters.
Jump Financial's Avita Medical position peaked at $417K in Q2 2023.
84 funds tracked by Wall St. Rank held Avita Medical as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.